AU3438699A - Biallelic markers for use in constructing a high density disequilibrium map of the human genome - Google Patents

Biallelic markers for use in constructing a high density disequilibrium map of the human genome

Info

Publication number
AU3438699A
AU3438699A AU34386/99A AU3438699A AU3438699A AU 3438699 A AU3438699 A AU 3438699A AU 34386/99 A AU34386/99 A AU 34386/99A AU 3438699 A AU3438699 A AU 3438699A AU 3438699 A AU3438699 A AU 3438699A
Authority
AU
Australia
Prior art keywords
constructing
high density
human genome
biallelic markers
disequilibrium map
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34386/99A
Inventor
Marta Blumenfeld
Ilya Chumakov
Daniel Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Publication of AU3438699A publication Critical patent/AU3438699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU34386/99A 1998-04-21 1999-04-21 Biallelic markers for use in constructing a high density disequilibrium map of the human genome Abandoned AU3438699A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8261498P 1998-04-21 1998-04-21
US60082614 1998-04-21
US10973298P 1998-11-23 1998-11-23
US60109732 1998-11-23
PCT/IB1999/000822 WO1999054500A2 (en) 1998-04-21 1999-04-21 Biallelic markers for use in constructing a high density disequilibrium map of the human genome

Publications (1)

Publication Number Publication Date
AU3438699A true AU3438699A (en) 1999-11-08

Family

ID=26767666

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34386/99A Abandoned AU3438699A (en) 1998-04-21 1999-04-21 Biallelic markers for use in constructing a high density disequilibrium map of the human genome

Country Status (4)

Country Link
EP (1) EP1071817A2 (en)
AU (1) AU3438699A (en)
CA (1) CA2324866A1 (en)
WO (1) WO1999054500A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7058517B1 (en) 1999-06-25 2006-06-06 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
AU2699901A (en) * 2000-01-13 2001-07-24 Serono Genetics Institute S.A. Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders
US6562955B2 (en) * 2000-03-17 2003-05-13 Tosoh Corporation Oligonucleotides for detection of Vibrio parahaemolyticus and detection method for Vibrio parahaemolyticus using the same oligonucleotides
US6931326B1 (en) 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
IL153927A0 (en) * 2000-07-18 2003-07-31 Genset Sa Genomic maps comprising biallelic markers, new such markers and the use of biallelic markers
GB0021667D0 (en) * 2000-09-04 2000-10-18 Glaxo Group Ltd Genetic study
DE10050361A1 (en) * 2000-10-11 2002-04-18 Genprofile Ag Statistical processing of gene sequences to determine possible haplotypes and their probability, useful e.g. for identifying genetic origins of complex diseases
WO2002035442A2 (en) * 2000-10-23 2002-05-02 Glaxo Group Limited Composite haplotype counts for multiple loci and alleles and association tests with continuous or discrete phenotypes
JP4757402B2 (en) * 2001-05-23 2011-08-24 キリンホールディングス株式会社 Polynucleotide probes and primers for detection of beer-turbid lactic acid bacteria and detection methods for beer-turbid lactic acid bacteria
AUPR823601A0 (en) * 2001-10-12 2001-11-08 University Of Queensland, The Automated genotyping
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
WO2005048012A2 (en) * 2003-08-05 2005-05-26 Genaissance Pharmaceuticals, Inc. Methods for haplotype assignment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858659A (en) * 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
AU8132194A (en) * 1993-11-03 1995-05-23 Molecular Tool, Inc. Single nucleotide polymorphisms and their use in genetic analysis
WO1998020165A2 (en) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Biallelic markers
EP0892068A1 (en) * 1997-07-18 1999-01-20 Genset Sa Method for generating a high density linkage disequilibrium-based map of the human genome
DE69800415T2 (en) * 1997-12-22 2001-07-19 Genset Paris PROSTATE CANCER GENE

Also Published As

Publication number Publication date
EP1071817A2 (en) 2001-01-31
WO1999054500A3 (en) 2000-03-16
WO1999054500A9 (en) 2000-02-10
WO1999054500A2 (en) 1999-10-28
CA2324866A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
AU5639900A (en) Shaped scalpel
AU2211400A (en) Expandable cannula
WO1999004038A3 (en) Biallelic markers for use in constructing a high density disequilibrium map of the human genome
AU2001269681A1 (en) Battery-powered cathodic protection system
GB9912411D0 (en) Compounds useful in therapy
GB9912413D0 (en) Compounds useful in therapy
AU1101699A (en) Therapeutic pillow
AU3438699A (en) Biallelic markers for use in constructing a high density disequilibrium map of the human genome
AUPQ008799A0 (en) Genome sequencing
AUPP230498A0 (en) In line leach reactor
AU6633600A (en) Restriction indicator
GB9912410D0 (en) Compounds useful in therapy
AU2001293074A1 (en) Human liver cell line
AU2002232419A1 (en) Clinician's assistant system
AUPP193498A0 (en) Cemetery walls
GB9912416D0 (en) Compounds useful in therapy
AU2001245953A1 (en) Oncogenic osteomalacia-related gene 1
AU6328799A (en) Organophosphorous compounds and use thereof
AUPQ314799A0 (en) Bone cell factor
AU6247598A (en) Asthma related genes
GB9828383D0 (en) Cell lineage markers
AUPP798298A0 (en) Tiered fountain or pond
AU5492600A (en) Computer navigation aid
HK1025467A2 (en) Computer-aided quote tracking
GB9925223D0 (en) Wheelchair

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase